|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Complete development and long-term maintenance of Cryptosporidium parvum human and cattle genotypes in cell culture显示文摘 | Hijjawi NS Meloni BP Morgan UM | 2001 | Int J Parasitol2001，31，10： | 1 |
| 2 | Cross-linking of CD59 and of other glycosylphosphatidylinositd-anchored molecules on neutrophils triggers cell activation via tyrosine kinase显示文摘 | Morgan BP Avies EV Allett MB | 1993 | Immunol1993，23，： | 1 |
| 3 | Cardiac myosin acnvatmn part 1: Form concept to clinic显示文摘 | Malik FI Morgan BP | 2011 | J Mol Cell Car- diol2011，51，4： | 1 |
| 4 | The glycosylation of the complement regulatory protein, human erythrocyte CD59 显示文摘 | MORGAN BP WORMALD MR | 1997 | J Biol Chem1997，272，11： | 1 |
| 5 | Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cells显示文摘 | Harris CL Morgan BP | 1999 | J Immunol Meth1999，224，： | 1 |
| 6 | A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement 显示文摘 | Ling M Piddlesden SJ Morgan BP | 1995 | Clin Exp Im- munol1995，102，3： | 1 |
| 7 | Effects of the membrane attack complex of complement on nucleated cells显示文摘 | Morgan BP | 1992 | Curt Top Microbiol Immunol1992，178，56： | 1 |
| 8 | Functional basis of protection against age - related macular degeneration conferred by a common pol- ymorphism in complement factor B 显示文摘 | Montes T Tortajada A Morgan BP | 2009 | Proc Natl Sci USA2009，106，11： | 1 |
| 9 | The human complement fragment receptor,C5L2,is a recycling decoy receptor显示文摘 | Scola AM Johswich KO Morgan BP | 2009 | Molecular Immunology2009，46，6： | 1 |
| 10 | Human protectin (CD59), an 18,000 - 20,000MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers 显示文摘 | Meri S Morgan BP Davies A | 1990 | Immunology1990，71，1： | 1 |
| 11 | Mechanisms of complement resistance induced by non-lethal complement attack and by growth arrest 显示文摘 | Marchbank KJ Van Den Berg Morgan BP | 1997 | Immunology1997，90，： | 1 |
| 12 | Complement therapeutics; history and current progress显示文摘 | Morgan BP Harris CL | 2003 | Mol Immunol2003，40，224： | 1 |
| 13 | Complement therapeutics;history and current progress显示文摘 | Morgan BP Harris CL | 2003 | Mol Immunol2003，40，24： | 1 |
| 14 | Expression of complement in the brain:role in health and disease显示文摘 | Morgan BP Gasque P | 1996 | Immunol Today1996，17，10： | 1 |
| 15 | Physiology and pathophysiology of compliment:Process and trends显示文摘 | Morgan Bp | 1995 | Crit Rev Clin Lab Scie1995，32，： | 1 |
| 16 | Complement regulation in the rat glomeruius: crry and CD59 regulate complement in glomerular mesangial and endothelial cells显示文摘 | Quigg R J Morgan BP Holers VW | 1995 | Kidney Int1995，48，6： | 1 |
| 17 | Physiology and Pathophysiology of Complement: Progress and Trends显示文摘 | Morgan BP McGeer PL | 1995 | Crit Rev Clin Lab Sci1995，32，3： | 1 |
| 18 | Production and functional characterization of a soluble recombinant from of mouse CD59显示文摘 | Rushmere NK Van Den Berg CW Morgan BP | 2000 | Immunology2000，99，2： | 1 |
| 19 | Human protectin(CD59), an 1 8 000-20 000 MW complement lysis restricting factor, inhibits C5b- 8 catalysed insertion of C9 into lipid bilayers 显示文摘 | Meri S Morgan BP Davies A | 1990 | Immunology1990，71，1： | 1 |
| 20 | Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46) 显示文摘 | Mead R Hinchliffe SJ Morgan BP | 1999 | Immunology1999，98，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员